Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17169179 | 0.80 | NPSR1 (0.61) | NPSR1GAA | |
| SCHEMBL4922666 | 0.75 | NPSR1 (0.44) | NPSR1GAA | |
| SCHEMBL4749839 | 0.72 | NPSR1 (0.61) | NPSR1GAA | |
| SCHEMBL28945078 | 0.70 | NPSR1 (0.55) | NPSR1GAA | |
| SCHEMBL4922662 | 0.69 | NPSR1 (0.53) | NPSR1GAA | |
| SCHEMBL27600043 | 0.69 | NPSR1 (0.53) | NPSR1GAA | |
| SCHEMBL19798472 | 0.69 | NPSR1 (0.69) | NPSR1GAA | |
| SCHEMBL906786 | 0.68 | NPSR1 (0.52) | NPSR1GAA | |
| SCHEMBL19391909 | 0.68 | NPSR1 (0.52) | NPSR1GAA | |
| SCHEMBL4749836 | 0.67 | NPSR1 (0.67) | NPSR1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2667192-B1 | Luminogenic and nonluminogenic multiplex assay | PROMEGA CORP (US) | 2020-10-07 | — | — | EP | disclosed |
| US-10745365-B2 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | PROMEGA CORPORATION (US) | 2020-08-18 | — | — | US | disclosed |
| EP-3312292-B1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORP (US) | 2019-09-25 | — | — | EP | disclosed |
| EP-1885875-B1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORP (US) | 2019-05-22 | — | — | EP | disclosed |
| US-20190031629-A1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2019-01-31 | — | — | US | disclosed |
| US-10077244-B2 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | PROMEGA CORPORATION (US) | 2018-09-18 | — | — | US | disclosed |
| EP-3312292-A1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | Promega Corporation (US) | 2018-04-25 | — | — | EP | disclosed |
| EP-2778234-B1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORP (US) | 2017-09-27 | — | — | EP | disclosed |
| US-20160176830-A1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2016-06-23 | — | — | US | disclosed |
| EP-2331517-B1 | BIOLUMINESCENT ASSAYS USING CYANOBENZOTHIAZOLE COMPOUNDS | PROMEGA CORP (US) | 2016-06-08 | — | — | EP | disclosed |
| CN-101084437-A | Luminescent and non-luminescent multiplex assays | PROMEGA CORP (US) | 2007-12-05 | — | — | CN | disclosed |
| US-20070178545-A1 | Luminogenic and nonluminogenic multiplex assay | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2007-08-02 | — | — | US | disclosed |
| WO-2007027653-A1 | CELL-BASED LUMINOGENIC AND NONLUMINOGENIC PROTEASOME ASSAYS | PROMEGA CORPORATION (US) | 2007-03-08 | — | — | WO | disclosed |
| US-20070048812-A1 | Cell-based luminogenic and nonluminogenic proteasome assays | PROMEGA CORPORATION | 2007-03-01 | — | — | US | disclosed |
| US-20070015790-A1 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2007-01-18 | — | — | US | disclosed |
| WO-2006130551-A2 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | PROMEGA CORPORATION (US) | 2006-12-07 | — | — | WO | disclosed |
| EP-1711822-A2 | LUMINOGENIC AND NONLUMINOGENIC MULTIPLEX ASSAY | PROMEGA CORPORATION (US) | 2006-10-18 | — | — | EP | disclosed |
| WO-2005073722-A2 | LUMINOGENIC AND NONLUMINOGENIC MULTIPLEX ASSAY | PROMEGA CORPORATION (US) | 2005-08-11 | — | — | WO | disclosed |
| US-20050164321-A1 | Colorimetric analysis; kits | PROMEGA CORPORATION | 2005-07-28 | — | — | US | disclosed |
| US-5580741-A | INCUBATING SAMPLE SOLUTION IN CONTAINER PRECOATED WITH ANTIBODY AND PROTEIN CONJUGATE YIELDS COMPLEXES, THEN REMOVAL AND REACTION WITH CHEMILUMINESCENT REAGENTS FOR MEASUREMENT OF LIGHT INTENSITY, FOR CHLORINATED BIPHENYLS | GENERAL ELECTRIC COMPANY (US) | 1996-12-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10745365-B2 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | GLB1, NOD1, PYCARD | NPSR1 2510/4885GAA 278/4885 |
| US-10077244-B2 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | GLB1, NOD1, PYCARD | NPSR1 2474/4885GAA 277/4885 |
| US-20190031629-A1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | GLB1, NOD1, PYCARD | NPSR1 2510/4885GAA 278/4885 |
| US-20160176830-A1 | LUMINOGENIC AND FLUOROGENIC COMPOUNDS AND METHODS TO DETECT MOLECULES OR CONDITIONS | GLB1, NOD1, PYCARD | NPSR1 2474/4885GAA 277/4885 |
| US-20070015790-A1 | Luminogenic and fluorogenic compounds and methods to detect molecules or conditions | GLB1, NOD1, PYCARD | NPSR1 2514/4885GAA 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.